CATALOGO DEI PRODOTTI DELLA RICERCA

Carbone, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.425
EU - Europa 1.227
AS - Asia 533
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
AF - Africa 1
Totale 3.198
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.419
CN - Cina 417
GB - Regno Unito 413
IT - Italia 230
SE - Svezia 151
IE - Irlanda 118
DE - Germania 109
FR - Francia 95
FI - Finlandia 59
SG - Singapore 38
VN - Vietnam 33
UA - Ucraina 21
HK - Hong Kong 20
BE - Belgio 12
JP - Giappone 11
NL - Olanda 6
AU - Australia 5
CA - Canada 5
KR - Corea 5
EU - Europa 3
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
ID - Indonesia 1
IN - India 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.198
Salva come PNG Salva come JPEG
Città #
Southend 389
Chandler 357
Woodbridge 152
Jacksonville 124
Ashburn 122
Dublin 118
Beijing 87
Verona 83
Ann Arbor 75
Jinan 52
Wilmington 39
Lawrence 38
Princeton 38
Redmond 37
Houston 33
Nanjing 33
Shenyang 32
Helsinki 31
New York 30
Hebei 24
Tianjin 23
Singapore 21
Dong Ket 20
Hong Kong 18
Haikou 15
Taiyuan 15
Nanchang 14
Zhengzhou 14
Sindelfingen 13
Brussels 12
Ningbo 11
Seattle 11
Changsha 10
Tokyo 10
Guangzhou 9
Jiaxing 9
Redwood City 9
Boardman 8
Bologna 8
Hangzhou 8
Kent 8
Norwalk 7
Washington 6
Chicago 5
Fairfield 5
Isola della Scala 5
Nürnberg 5
Taizhou 5
Cagliari 4
Dearborn 4
Falls Church 4
Lancaster 4
Lanzhou 4
Rome 4
Seoul 4
Clearwater 3
Elora 3
Fuzhou 3
Los Angeles 3
San Francisco 3
Cattolica 2
Chieti 2
Düsseldorf 2
Giugliano In Campania 2
Glasgow 2
Jeffries 2
Lana 2
Leawood 2
Melbourne 2
Milan 2
Monza 2
Quartu Sant'elena 2
Sydney 2
Toronto 2
Trissino 2
Vienna 2
Villiers-sur-marne 2
Xiangfen 2
Agrigento 1
Almaty 1
Auburn Hills 1
Baku 1
Boston 1
Bratislava 1
Brno 1
Buccinasco 1
Böblingen 1
Büdelsdorf 1
Cairo 1
Canberra 1
Chaoyang 1
Crotone 1
Cutrofiano 1
Dallas 1
Des Moines 1
Dongguan 1
Dubai 1
Fort Worth 1
Fremont 1
Groningen 1
Totale 2.299
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 198
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 140
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. 130
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 128
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 112
NF-κB as a target for pancreatic cancer therapy. 108
TGF-beta-activated Kinase 1 (TAK1) is a therapeutic target modulating pancreatic cancer chemoresistance 104
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 104
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 103
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 102
Anti- VEGF treatment resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype 100
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT 96
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 94
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 94
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. 92
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 92
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 92
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 90
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents 89
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 83
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer 82
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 82
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy 77
EMT and Treatment Resistance in Pancreatic Cancer 71
Molecular alterations in basal cell carcinoma subtypes 66
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation 64
Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus 63
Toll-Like Receptor 9 Agonists for Cancer Therapy 63
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity 61
Rationale and clinical use of multitargeting anticancer agents. 58
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around 58
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 57
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy 56
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 50
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 42
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat 34
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis 29
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 28
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 26
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 25
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer 8
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 7
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 5
Totale 3.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.322
article - articoli 9.293
book - libri 0
conference - conferenze 711
curatela - curatele 0
other - altro 318
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020387 33 13 39 17 43 33 41 18 24 39 35 52
2020/2021387 43 33 20 53 42 39 7 8 10 55 34 43
2021/2022436 40 150 17 37 11 5 8 24 9 12 19 104
2022/2023820 70 104 75 149 52 200 4 46 96 7 11 6
2023/2024491 13 22 36 54 52 71 27 77 6 35 73 25
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 3.263